Quest Diagnostics introduces AD-Detect Abeta, a new laboratory blood test, to detect Alzheimer's disease without any PET ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced the launch of a new laboratory blood test designed to help ...

Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related ...

Quest Diagnostics (DGX) launched a new laboratory blood test designed to help physicians confirm amyloid brain pathology due to Alzheimer’s ...

These certs offer hands-on training and up-to-date curricula, equipping offensive security professionals with their choice of ...

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...

The engine was tested extensively and is poised to power hypersonic cruise missiles, with the trial successfully trialling a ...

NIOSH investigators identified a new lung disease in workers at factories that made microwave popcorn, and helped assess what ...

GT-02287 oral presentation demonstrates new evidence of disease-modifying capacity in GBA1 and idiopathic Parkinson's disease ...

The laboratory-developed test, named AD-Detect™ Abeta 42/40 and p-tau217 Evaluation, combines results of blood levels of amyloid beta (AB) 42/40 determined by the company’s proprietary tandem mass ...

Having a book on fermentation by Noma restaurant’s chef Rene Redzepi – among the dozens of other culinary titles in her ...

District leaders making several big changes and considering other overhauls as they contend with enrollment losses largely ...